Jobs / United States / Abbvie INC
Associate Director, Portfolio Insights – Neuroscience
Abbvie INC · 🇺🇸 North Chicago, IL, US
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie INC paid sponsored hires in similar roles10 certified filings for “ASSOCIATE DIRECTOR, STATISTICS” (Data Scientists) in IL: $117k–$165k, median $151k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbvie INC
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbvie INC →
About the role
The Portfolio Insights team is responsible for enabling AbbVie to make data-driven decisions on portfolio choices both within and across Therapeutic Areas (TAs). Portfolio Insights TA leads provide analytics and recommendations to drive better decision-making across the internal portfolio and BD opportunities on a project and TA-level. The Associate Director, Portfolio Insights – Neuroscience TA lead acts as the voice of Portfolio Insights for their Therapeutic Areas. They will be responsible for presenting and defending recommendations for Therapeutic Area leadership and driving the analytics and co-ordination of inputs across functions to deliver high quality insights. Responsibilities: • Deliver high-impact recommendations for their Therapeutic Areas on project value, trade-offs and scenarios to senior leadership within TAs and in AbbVie governance forums. • Proactively identify opportunities where valuation and economic analysis can drive higher quality decision making for asset strategy teams and TAs. • Build value metrics (e.g., raNPV, PI) and any required scenario analysis to drive effective drug development decisions, working with ASLs (asset strategy leaders), Search & Evaluation (S&E), program managers, pipeline commercial leads, forecasting teams and others. • Coach team members on valuations, economic analysis and best practices for data-driven decision-making. • Provide an unbiased assessment of PTRS (probability of technical and regulatory success) for drug development projects, working with clinical development and regulatory teams. • Recommend TA-level prioritization of projects within their therapeutic areas, working with TA leadership and members of the portfolio insights team. • Support on key business processes facilitated by the Portfolio Insights team as the voice of their Therapeutic Areas (including R&D Plan, Financial LRP, Quarterly Portfolio Prioritization, R&D Productivity). • Engage effectively with functional stakeholders (e.g., Finance, PPM) to drive appropriate linkages and constructively pressure testing assumptions/ inputs • Work on continuous improvement efforts within Portfolio Insights to improve the team’s ability to act as proactive strategic advisors that leverage modernized approaches (including AI/ML based predictive solutions) to drive better-decision making for the Portfolio. • Conduct ad-hoc short-term analyses or strategic projects at leadership request • Bachelor’s degree in scientific or business field required; MBA and PhD in scientific field preferred • 7-10 years of experience with multi-faceted, broad based understanding of Pharma R&D business processes, investment stage gating and commercial processes; fewer years can be considered if candidate has advanced degrees (MBA, PhD) • Excellent analytical and problem-solving skills with attention to details • Experience with multi-faceted, broad based understanding of Pharma R&D business processes, investment stage gating and commercial processes • Demonstrated experience working in fast paced settings, with a proven track record of delivering high quality and insightful analyses • Effective oral and written communication skills with proven ability to tailor analytical outputs to different audiences • Strong presence in meetings with willingness to navigate different functional perspectives and push for “enterprise thinking” • Strong organizational and project management skills commensurate with conducting multiple sophisticated analyses across several assets • Prior experience in Management Consulting and track record of experience in R&D Strategy / Portfolio prioritization projects a plus • This role is hybrid requiring at least three (3) days onsite, Tuesday through Thursday in our A